Is Guardant Health Inc (GH) underperforming its competitors in share price?
Statistics show that Guardant Health Inc. has underperformed its competitors in share price, compared to the industry in which it operates. Guardant Health Inc. (GH) shares have gone up 31. 00% during the last six months, with a year-to-date growth rate less than the industry average at -58. 50% against 4. 40.
What is the average price target for Guardant Health?
According to 8 analyst offering 12-month price targets in the last 3 months, Guardant Health has an average price target of $79.0 with a high of $99.00 and a low of $50.00. Below is a summary of how these 8 analysts rated Guardant Health over the past 3 months.
What to expect from Guardant Health (Guardant) earnings in 2023?
With its current market valuation of $5. 30 billion, Guardant Health Inc. is set to declare its quarterly results on Feb 21, 2023 – Feb 27, 2023. Analysts are in estimates of -$1. 26 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$5. 79 for 2022 with estimates of that growing to -$4.
Takeda Dengue Vaccine Receives Positive CHMP Opinion
8:54 - 3 months ago
Returning guest, Dr. Derek Wallace, MBBS, Vice President and Global Dengue Program Head at Takeda discusses the news that ...
We are confident that you have many more questions about Guardant Health News, and the only way to satisfy your thirst for knowledge is to gather information from as many trustworthy online sources as possible.
Possible resources for Guardant Health News include guides, rating websites, word-of-mouth testimonials, online forums, and product reviews. To ensure that you obtain the best Guardant Health News, it is essential to conduct exhaustive and thorough research. Ensure that only trustworthy and credible websites and sources are used.
We provide a infomation guide for the Guardant Health News, and all of the information is objective and genuine. We use both artificial intelligence and big data to proofread the collected information.
How was this guide created?
Using a custom-built set of algorithms, we were able to generate a top-ten list of the ten best equal Guardant Health News currently available on the internet.
Kintara Therapeutics - Seeking New Horizons for Cancer Patients with Novel Therapies
9:38 - 3 months ago
Robert Hoffman, President and CEO at Kintara Therapeutics, a company dedicated to the development of unique anti-cancer ...